(-1.38%) 5 001.49 points
(-1.79%) 37 774 points
(-1.74%) 15 439 points
(-0.70%) $82.23
(-2.06%) $1.619
(0.73%) $2 355.50
(0.93%) $27.60
(0.39%) $919.40
(-0.14%) $0.933
(0.02%) $10.99
(-0.27%) $0.800
(-0.32%) $92.03
Live Chart Being Loaded With Signals
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide...
Stats | |
---|---|
Today's Volume | 426 363 |
Average Volume | 304 353 |
Market Cap | 14.86B |
EPS | $0.125 ( 2020-09-29 ) |
Last Dividend | $0.212 ( 2023-06-26 ) |
Next Dividend | $0 ( N/A ) |
P/E | 62.07 |
ATR14 | $0.0410 (0.16%) |
Volume Correlation
Fisher & Paykel Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Fisher & Paykel Correlation - Currency/Commodity
Fisher & Paykel Financials
Annual | 2023 |
Revenue: | $1.49B |
Gross Profit: | $885.34M (59.54 %) |
EPS: | $0.410 |
Q2 | 2024 |
Revenue: | $760.14M |
Gross Profit: | $464.21M (61.07 %) |
EPS: | $0.170 |
Q4 | 2023 |
Revenue: | $836.86M |
Gross Profit: | $494.94M (59.14 %) |
EPS: | $0.250 |
Q3 | 2022 |
Revenue: | $415.31M |
Gross Profit: | $244.94M (58.98 %) |
EPS: | $0.120 |
Financial Reports:
No articles found.
Fisher & Paykel Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.165 (N/A) |
$0 (N/A) |
$0.212 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0500 | 2002-06-07 |
Last Dividend | $0.212 | 2023-06-26 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 42 | -- |
Total Paid Out | $3.24 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.12 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.73 | |
Div. Directional Score | 9.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LSF.AX | Ex Dividend Knight | 2023-09-11 | Semi-Annually | 0 | 0.00% | |
TAH.AX | Ex Dividend Junior | 2023-08-31 | Annually | 0 | 0.00% | |
CSR.AX | Ex Dividend Knight | 2023-05-26 | Annually | 0 | 0.00% | |
NCM.AX | Ex Dividend Knight | 2023-10-18 | Semi-Annually | 0 | 0.00% | |
WPR.AX | Ex Dividend Junior | 2023-06-29 | Quarterly | 0 | 0.00% | |
FAR.AX | No Dividend Player | 2023-08-23 | Sporadic | 0 | 0.00% | |
PL8.AX | Ex Dividend Knight | 2023-09-14 | Monthly | 0 | 0.00% | |
APE.AX | Ex Dividend Junior | 2023-09-01 | Annually | 0 | 0.00% | |
HZN.AX | Ex Dividend Knight | 2023-10-17 | Annually | 0 | 0.00% | |
RWC.AX | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.153 | 1.500 | 6.94 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.110 | 1.200 | 6.34 | 7.61 | [0 - 0.3] |
returnOnEquityTTM | 0.144 | 1.500 | 9.51 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.563 | -1.000 | 4.37 | -4.37 | [0 - 1] |
currentRatioTTM | 2.54 | 0.800 | 2.29 | 1.830 | [1 - 3] |
quickRatioTTM | 1.059 | 0.800 | 8.48 | 6.78 | [0.8 - 2.5] |
cashRatioTTM | 0.246 | 1.500 | 9.75 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.128 | -1.500 | 7.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 26.34 | 1.000 | 1.354 | 1.354 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.632 | 2.00 | 9.79 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0505 | 2.00 | 9.97 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.174 | -1.500 | 9.30 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.601 | 1.000 | 3.32 | 3.32 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.219 | 1.000 | 7.63 | 7.63 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.288 | 1.000 | 3.95 | 3.95 | [0.2 - 2] |
assetTurnoverTTM | 0.717 | 0.800 | 8.56 | 6.84 | [0.5 - 2] |
Total Score | 11.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 60.43 | 1.000 | 4.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.144 | 2.50 | 9.68 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0505 | 2.00 | 9.98 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.311 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.632 | 2.00 | 9.79 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.563 | 1.500 | 4.37 | -4.37 | [0 - 1] |
pegRatioTTM | 3.63 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.230 | 1.000 | 6.75 | 0 | [0.1 - 0.5] |
Total Score | 6.73 |
Fisher & Paykel
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators